[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_17340 

# __Quality-related concerns over drug efficacy, safety, and surveillance__

## Articles mentionning the risk

* [Obonyo_decision_2018](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_628.md)

## Mitigations of this risk

* [Enhanced surveillance, drug development, and safety regulations](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_19295.md)

## Name of the risk

Potential decrease in intervention effectiveness, drug resistance

## People affected by this risk

* [Healthcare professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_32.md)
* [Populations at risk of malaria](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_13855.md)

## Stakeholders who can mitigate this risk

* [Health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_422.md)
* [Regulatory agencies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_401.md)

## Technologies linked to the risk

* [Drug development technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1261.md)
* [Drug quality testing tools](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_19732.md)
* [Surveillance technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_19733.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

